These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 9393981

  • 1. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors.
    Kovar H, Jug G, Aryee DN, Zoubek A, Ambros P, Gruber B, Windhager R, Gadner H.
    Oncogene; 1997 Oct; 15(18):2225-32. PubMed ID: 9393981
    [Abstract] [Full Text] [Related]

  • 2. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
    Fuxe J, Akusjärvi G, Goike HM, Roos G, Collins VP, Pettersson RF.
    Cell Growth Differ; 2000 Jul; 11(7):373-84. PubMed ID: 10939591
    [Abstract] [Full Text] [Related]

  • 3. Expression of cyclin D1, CDK4 and p27KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines.
    Kitahara K, Yasui W, Yokozaki H, Semba S, Hamamoto T, Hisatsugu T, Tahara E.
    J Exp Ther Oncol; 1996 Jan; 1(1):7-12. PubMed ID: 9414383
    [Abstract] [Full Text] [Related]

  • 4. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
    Sonoda Y, Yoshimoto T, Sekiya T.
    Oncogene; 1995 Nov 16; 11(10):2145-9. PubMed ID: 7478535
    [Abstract] [Full Text] [Related]

  • 5. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
    Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J, Bartek J.
    Cancer Res; 1996 Dec 01; 56(23):5475-83. PubMed ID: 8968104
    [Abstract] [Full Text] [Related]

  • 6. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia.
    Guo SX, Taki T, Ohnishi H, Piao HY, Tabuchi K, Bessho F, Hanada R, Yanagisawa M, Hayashi Y.
    Leuk Res; 2000 Jan 01; 24(1):39-46. PubMed ID: 10634644
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.
    Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, Peters G, Bartek J.
    Nature; 1995 Jun 08; 375(6531):503-6. PubMed ID: 7777060
    [Abstract] [Full Text] [Related]

  • 12. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
    Eissa S, Ahmed MI, Said H, Zaghlool A, El-Ahmady O.
    IUBMB Life; 2004 Sep 08; 56(9):557-64. PubMed ID: 15590562
    [Abstract] [Full Text] [Related]

  • 13. Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma.
    Gao L, Liu L, van Meyel D, Cairncross G, Forsyth P, Kimmel D, Jenkins RB, Lassam NJ, Hogg D.
    Clin Cancer Res; 1997 Jun 08; 3(6):977-81. PubMed ID: 9815774
    [Abstract] [Full Text] [Related]

  • 14. Infrequent mutation of the p16/MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcoma.
    Yao J, Pollock RE, Lang A, Tan M, Pisters PW, Goodrich D, El-Naggar A, Yu D.
    Clin Cancer Res; 1998 Apr 08; 4(4):1065-70. PubMed ID: 9563903
    [Abstract] [Full Text] [Related]

  • 15. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
    Nielsen GP, Burns KL, Rosenberg AE, Louis DN.
    Am J Pathol; 1998 Jul 08; 153(1):159-63. PubMed ID: 9665476
    [Abstract] [Full Text] [Related]

  • 16. Expression of the cell-cycle regulatory proteins (pRb, cyclin D1, p16INK4A and cdk4) in human endometrial cancer: correlation with clinicopathological features.
    Semczuk A, Miturski R, Skomra D, Jakowicki JA.
    Arch Gynecol Obstet; 2004 Jan 08; 269(2):104-10. PubMed ID: 14648178
    [Abstract] [Full Text] [Related]

  • 17. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
    Havrilesky LJ, Alvarez AA, Whitaker RS, Marks JR, Berchuck A.
    Gynecol Oncol; 2001 Dec 08; 83(3):491-500. PubMed ID: 11733961
    [Abstract] [Full Text] [Related]

  • 18. Abnormalities of p16, p15 and CDK4 genes in recurrent malignant astrocytomas.
    Saxena A, Robertson JT, Ali IU.
    Oncogene; 1996 Aug 01; 13(3):661-4. PubMed ID: 8760309
    [Abstract] [Full Text] [Related]

  • 19. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A, Gaddipati JP, Moul JW, Srivastava S.
    J Urol; 1998 May 01; 159(5):1725-30. PubMed ID: 9554401
    [Abstract] [Full Text] [Related]

  • 20. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB, Rutka JT, Hubbard SL, Mondal S, Hamel PA.
    Oncogene; 1998 Aug 20; 17(7):867-76. PubMed ID: 9780003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.